Card image cap

Henry Waxman's Public Statements on Issue: Drugs

Current Issue:

Drugs

Speech Type

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Page 1 of 3
Date Title
09/15/2014 Designer Anabolic Steroid Control Act of 2014
04/29/2014 Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - Examining the Growing Problems of Prescription Drug and Heroin Abuse
04/08/2014 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Examining the Implementation of the Tobacco Control Act
04/07/2014 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Improving Predictability and Transparency in DEA and FDA Regulation
04/01/2014 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Examining Concerns Regarding FDA's Proposed Changes to Generic Drug Labeling
02/27/2014 Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - Counterfeit Drugs: Fighting Illegal Supply Chains
11/08/2013 Leahy Leads Coalition of Lawmakers in Welcoming the FDA's Release of Proposed Rules To Protect Consumers Using Generic Drugs
07/16/2013 Hearing of the House Health Subcommittee of the Energy and Commerce Committee - Reforming the Drug Compounding Regulatory Framework
06/17/2013 Rep. Waxman Statement on Supreme Court Decision on Generic Drug Competition
06/14/2013 Hearing of the House Health Subcommittee of the Energy and Commerce Committee - Examining the Federal Government's Response to the Prescription Drug Abuse Crisis
10/09/2012 Letter to Chairman Upton, Chairman Pitts, and Chairman Stearns
03/27/2012 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Examining the Current State of Cosmetics
03/20/2012 Letter to Jon Leibowitz, Chairman Federal Trade Commission - Pharmacy Merger
03/01/2012 Hearing of the Commerce, Manufacturing, and Trade Subcommittee of the House Energy and Commerce Committee - Prescription Drug Diversion: Combating the Scourge
01/01/2012 Issue Position: Health - Tobacco
01/01/2012 Issue Positions: Affordable Medications
01/01/2012 Issue Position: Health - Drug and Medical Device Safety
01/01/2012 Issue Position: Health - Affordable Medications
01/01/2012 Issue Position: Judiciary
01/01/2012 Issue Position: Federal Drug Policy
12/07/2011 Synthetic Drug Control Act of 2011
10/25/2011 Letter to Chairman Upton
10/13/2011 Letter to The Honorable Patty Murray Chairwoman and The Honorable Jeb Hensarling Chairman Joint Select Committee for Deficit Reduction
06/16/2011 House Democratic Leaders Introduce Legislation to Save More Than $100 Billion in Medicare Drug Costs
06/01/2011 House Appropriations Committee Passes Bill to Weaken Critical FDA Public Health Functions
Page 1 of 3
arrow_upward